Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)

CUSIP: 05156V102

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / Common Shares, no par value
Shares outstanding
132,929,348
Total 13F shares
22,212,575
Share change
+705,959
Total reported value
$151,471,995
Put/Call ratio
229%
Price per share
$6.82
Number of holders
59
Value change
+$3,053,577
Number of buys
20
Number of sells
28

Quarterly Holders Quick Answers

What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
NEA Management Company, LLC
13F
Company
3.6%
4,808,483
$31,928,000 30 Sep 2018
13F
FMR LLC
13F
Company
3.5%
4,680,959
$31,082,000 30 Sep 2018
13F
Polar Capital LLP
13F
Company
2.1%
2,811,516
$18,668,000 30 Sep 2018
13F
FRANKLIN RESOURCES INC
13F
Company
1.4%
1,838,500
$12,208,000 30 Sep 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.3%
1,743,340
$11,576,000 30 Sep 2018
13F
Vivo Capital, LLC
13F
Company
0.91%
1,213,290
$8,056,000 30 Sep 2018
13F
BlackRock Finance, Inc.
13F
Company
0.74%
982,885
$6,526,000 30 Sep 2018
13F
Abingworth LLP
13F
Company
0.3%
400,434
$2,655,000 30 Sep 2018
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.28%
369,352
$2,452,000 30 Sep 2018
13F
Hudson Bay Capital Management LP
13F
Company
0.26%
342,500
$2,274,000 30 Sep 2018
13F
Cornerstone Wealth Management, LLC
13F
Company
0.01%
12,840
$2,000,000 30 Sep 2018
13F
D. E. Shaw & Co., Inc.
13F
Company
0.2%
263,871
$1,752,000 30 Sep 2018
13F
IRONWOOD INVESTMENT MANAGEMENT LLC
13F
Company
0.16%
212,865
$1,413,000 30 Sep 2018
13F
Kazazian Asset Management, LLC
13F
Company
0.13%
170,356
$1,131,000 30 Sep 2018
13F
S.c.a. Candriam
13F
Individual
0.12%
157,500
$1,046,000 30 Sep 2018
13F
Creative Planning
13F
Company
0.11%
152,200
$1,011,000 30 Sep 2018
13F
CITADEL ADVISORS LLC
13F
Company
0.1%
136,185
$904,000 30 Sep 2018
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.1%
129,779
$862,000 30 Sep 2018
13F
UBS Group AG
13F
Company
0.1%
128,970
$857,000 30 Sep 2018
13F
GROUP ONE TRADING LLC
13F
Company
0.09%
115,489
$767,000 30 Sep 2018
13F
Swiss National Bank
13F
Company
0.07%
92,400
$608,000 30 Sep 2018
13F
BANK OF MONTREAL /CAN/
13F
Company
0.07%
88,995
$591,000 30 Sep 2018
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.06%
77,913
$517,000 30 Sep 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.05%
64,985
$431,000 30 Sep 2018
13F
Man Group plc
13F
Company
0.04%
57,700
$383,000 30 Sep 2018
13F
MORGAN STANLEY
13F
Company
0.04%
50,302
$334,000 30 Sep 2018
13F
STIFEL FINANCIAL CORP
13F
Company
0.03%
45,196
$300,000 30 Sep 2018
13F
Cutler Capital Management, LLC
13F
Company
0.04%
55,000
$254,000 30 Sep 2018
13F
ProShare Advisors LLC
13F
Company
0.03%
34,338
$228,000 30 Sep 2018
13F
JANE STREET GROUP, LLC
13F
Company
0.02%
27,358
$182,000 30 Sep 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
25,117
$167,000 30 Sep 2018
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
20,378
$135,000 30 Sep 2018
13F
Patriot Financial Group Insurance Agency, LLC
13F
Company
0.02%
20,000
$133,000 30 Sep 2018
13F
CREDIT SUISSE AG/
13F
Company
0.01%
19,027
$127,000 30 Sep 2018
13F
Spark Investment Management LLC
13F
Company
0.01%
18,000
$118,000 30 Sep 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
17,224
$114,000 30 Sep 2018
13F
VANGUARD GROUP INC
13F
Company
0.01%
14,771
$98,000 30 Sep 2018
13F
SIMPLEX TRADING, LLC
13F
Company
0.01%
14,057
$93,000 30 Sep 2018
13F
US BANCORP \DE\
13F
Company
0.01%
13,820
$92,000 30 Sep 2018
13F
MGO ONE SEVEN LLC
13F
Company
0.01%
11,000
$73,000 30 Sep 2018
13F
LEVIN CAPITAL STRATEGIES, L.P.
13F
Company
0.01%
10,000
$66,000 30 Sep 2018
13F
CANADA LIFE ASSURANCE Co
13F
Company
0.01%
6,730
$43,000 30 Sep 2018
13F
BROWN BROTHERS HARRIMAN & CO
13F
Company
0%
6,500
$43,000 30 Sep 2018
13F
TORONTO DOMINION BANK
13F
Company
0%
5,300
$35,000 30 Sep 2018
13F
SHELL ASSET MANAGEMENT CO
13F
Company
0%
5,200
$34,000 30 Sep 2018
13F
Federation Des Caisses Desjardins du Quebec
13F
Individual
0%
5,259
$33,400 30 Sep 2018
13F
TRUSTCORE FINANCIAL SERVICES, LLC
13F
Company
0%
4,590
$30,000 30 Sep 2018
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0%
3,000
$20,000 30 Sep 2018
13F
Zurcher Kantonalbank (Zurich Cantonalbank)
13F
Company
0%
2,276
$15,000 30 Sep 2018
13F
BENJAMIN F. EDWARDS & COMPANY, INC.
13F
Company
0%
2,000
$13,000 30 Sep 2018
13F

Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q4 2018

As of 31 Dec 2018, Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by 59 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,212,575 shares. The largest 10 holders included FMR LLC, NEA Management Company, LLC, Polar Capital LLP, FRANKLIN RESOURCES INC, GOLDMAN SACHS GROUP INC, Vivo Capital, LLC, BlackRock Inc., Abingworth LLP, D. E. Shaw & Co., Inc., and AMERIPRISE FINANCIAL INC. This page lists 59 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders
62
Q4 2018 holders
59
Holder diff
-3
Investor Q3 2018 Shares Q4 2018 Shares Share Diff Share Chg % Q3 2018 Value $ Q4 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .